Taiwan FDA registration 365d171d4aed677981e9ae3c32ecdfe3

Cimosir D Gemini High Sensitivity Tube Solution

TW: 希摩西爾D雙子高敏感度品管液
Taiwan flagTaiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A.·Registered Oct 18, 2012 – Oct 18, 2027Active
Registration details
Analysis ID
365d171d4aed677981e9ae3c32ecdfe3
Customs Code
DHA00602409605
Company information
Manufacturer Country
Spain;;United States
Authorized Representative
Werfen Taiwan Limited
Product details
Intended Use
Suitable for D Gemini Reagent quality control substance on ACL TOP series system.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.7320 Fibrinogen/Fibrinolysis Product Analysis
Import Information
import
Dates and status
Registration Date
Oct 18, 2012
Expiry Date
Oct 18, 2027
Companies making similar products

Top companies providing products similar to "Cimosir D Gemini High Sensitivity Tube Solution"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Cimosir D Gemini High Sensitivity Tube Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 365d171d4aed677981e9ae3c32ecdfe3 and manufactured by INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations